Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058987) titled 'Elucidation of the effects of asynchronous remote exercise therapy on patients with chronic respiratory diseases' on Oct. 1.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Active

Primary Sponsor: Institute - SBC Tokyo Medical University

Condition: Condition - Chronic respiratory diseases Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objectives of this study are twofold: To determine whether chronic respiratory disease patients who use asynchronous telerehabilitation at home can improve their physical function and health-related quality of life (HRQOL), and To determine whether continued asynchronous telerehabilitation can maintain the effects of improved exercise tolerance and HRQOL over the long term. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - In the intervention group, exercise therapy that can be performed at home, such as aerobic exercise and muscle strengthening exercises, will be prescribed by Recaval and instructed to the patients. Patients will visit the clinic approximately once every 4-5 weeks, at which time the assigned physical therapist will confirm the implementation of the exercise therapy and adjust the exercise load.The exercise load is determined based on the initial assessment results and set to maintain a modified Borg scale of 3-5. The implementation status can be checked online by the assigned physical therapist. Once a week, a reminder and empowerment message is sent via chat function by the physician or physical therapist. Interventions/Control_2 - The control group will continue their usual medical care until their next visit.

Eligibility: Age-lower limit - 40 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1.Patients diagnosed with COPD or IIPs and currently receiving outpatient care at the Department of Respiratory Medicine at Toyo University Medical Center Oomori Hospital or Yokocho Hospital 2.Patients aged 40 years or older at the time of consent acquisition 3.Patients who are able to walk independently 4.Patients whom a physician determines are capable of undergoing accurate pulmonary function tests and walking tests 5.Patients whose condition is stable and have not undergone any changes in treatment for over three months 6.Individuals who own a smartphone, tablet, or computer and are deemed capable of using this service 7.Patients who have received adequate explanation of the study content and have provided written informed consent 8.Patients currently enrolled in or who have completed an outpatient rehabilitation program, with stable symptoms, and who do not have an outpatient rehabilitation program scheduled during the course of this trial Key exclusion criteria - 1.Patients with severe orthopedic or central nervous system disorders requiring assistance in daily living 2.Patients with a history of hospitalization within the past 6 months due to worsening of the underlying disease 3.Patients with unstable heart disease 4.Other patients for whom participation in this clinical study may compromise patient safety, or patients for whom compliance with the clinical study protocol is deemed difficult. Target Size - 40

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 08 Month 20 Day Date of IRB - 2025 Year 09 Month 01 Day Anticipated trial start date - 2025 Year 11 Month 20 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067237

Disclaimer: Curated by HT Syndication.